| Molecular genetics and cellular events of K-Ras-driven tumorigenesis GG Jinesh, V Sambandam, S Vijayaraghavan, K Balaji, S Mukherjee Oncogene 37 (7), 839-846, 2018 | 94 | 2018 |
| Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein A Arzumanyan, V Sambandam, MM Clayton, SS Choi, G Xie, AM Diehl, ... Cancer research 72 (22), 5912-5920, 2012 | 79 | 2012 |
| Genomic characterization of human papillomavirus-positive and-negative human squamous cell cancer cell lines NN Kalu, T Mazumdar, S Peng, L Shen, V Sambandam, X Rao, Y Xi, L Li, ... Oncotarget 8 (49), 86369, 2017 | 62 | 2017 |
| PDK1 Mediates NOTCH1-Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition V Sambandam, MJ Frederick, L Shen, P Tong, X Rao, S Peng, R Singh, ... Clinical Cancer Research 25 (11), 3329-3340, 2019 | 49 | 2019 |
| In silico analysis of DosR regulon proteins of Mycobacterium tuberculosis S Selvaraj, V Sambandam, D Sardar, S Anishetty Gene 506 (1), 233-241, 2012 | 31 | 2012 |
| Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors M Zhang, R Singh, S Peng, T Mazumdar, V Sambandam, L Shen, P Tong, ... Cancer letters 392, 71-82, 2017 | 28 | 2017 |
| Chromosome 3q26 gain is an early event driving coordinated overexpression of the PRKCI, SOX2, and ECT2 oncogenes in lung squamous cell carcinoma Y Liu, N Yin, X Wang, A Khoor, V Sambandam, AB Ghosh, ZA Fields, ... Cell reports 30 (3), 771-782. e6, 2020 | 24 | 2020 |
| Non‐canonical cM et regulation by vimentin mediates Plk1 inhibitor–induced apoptosis R Singh, S Peng, P Viswanath, V Sambandam, L Shen, X Rao, B Fang, ... EMBO Molecular Medicine 11 (5), e9960, 2019 | 19 | 2019 |
| Sustained Aurora kinase B expression confers resistance to PI3K inhibition in head and neck squamous cell carcinoma PA Shah, V Sambandam, AM Fernandez, H Zhao, T Mazumdar, L Shen, ... Cancer research 82 (23), 4444-4456, 2022 | 2 | 2022 |
| PI3K/mTOR pathway inhibition induces Aurora B mediated cell death in NOTCH1 mutant head and neck squamous (HNSCC) cells V Sambandam, L Shen, P Tong, S Peng, T Mazumdar, R Singh, ... Cancer Research 78 (13_Supplement), 2977-2977, 2018 | 2 | 2018 |
| Identification of NOTCH1 inactivating mutation as a therapeutic vulnerability to PI3K/mTOR pathway inhibition in head and neck squamous cell carcinoma (HNSCC) V Sambandam, L Shen, P Tong, T Mazumdar, C Pickering, JN Myers, ... Cancer Research 77 (13_Supplement), 2992-2992, 2017 | 2 | 2017 |
| Aurora kinase B expression shields HNSCC from PI3K inhibition-induced apoptosis through downstream mediators AKT and PDK1 PA Shah, AM Fernandez, V Sambandam, H Zhao, T Mazumdar, L Shen, ... Cancer Research 82 (12_Supplement), 3251-3251, 2022 | 1 | 2022 |
| Aurora kinases mediate resistance to PI3K inhibition in head and neck squamous cell carcinoma V Sambandam, T Mazumdar, L Shen, H Zhao, S Peng, J Wang, ... International Journal of Radiation Oncology, Biology, Physics 106 (5), 1184, 2020 | 1 | 2020 |
| NOTCH1 inactivating mutation mediates sensitivity to PI3K/mTOR inhibitors in head and neck squamous cell carcinoma FM Johnson, V Sambandam, L Shen, M Zhang, R Saigal, P Tong, ... Cancer Research 76 (14_Supplement), 393-393, 2016 | 1 | 2016 |
| Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine JA Taverna, CN Hung, M Williams, R Williams, M Chen, S Kamali, ... Lung Cancer, 107533, 2024 | | 2024 |
| Correlation Revealed between Gemtuzumab-Ozogamicin Efficacy and CD33+ Expression in AML Primary Samples through a Novel AML in Vitro Model M Gilardi, G Kaushik, B Walling, V Sambandam, P Schiavini, S Cairo, ... Blood 142, 7151, 2023 | | 2023 |
| 1479 A Novel TumorGraft3D immune co-culture platform for high throughput immune-oncology screening T Light, V Sambandam, S Kamali, N Alban, Y Nallana, S Shaik, B Walling, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Ex Vivo Drug Testing of Patient-Derived Lung Organoids to Predict Treatment Responses for Personalized Medicine CN Hung, M Williams, R Williams, M Chen, S Kamali, V Sambandam, ... Preprints, 2023 | | 2023 |
| Ex vivo modeling of multiple myeloma: A novel drug sensitivity screening platform V Sambandam, S Inamdar, H Hsu, B Walling, P Schiviani, A Andar, ... Cancer Research 83 (7_Supplement), 207-207, 2023 | | 2023 |
| Abstract B19: Susceptibility of NOTCH1 mutant head and neck squamous carcinoma to PI3K/mTOR pathway inhibition via PDK1 V Sambandam, MJ Frederick, L Shen, P Tong, X Rao, S Peng, ... Molecular Cancer Research 18 (10_Supplement), B19-B19, 2020 | | 2020 |
Jing WangProfessor of Bioinformatics, University of Texas M.D.Anderson Cancer CenterVerified email at mdanderson.org
